Study Shows Kidney Transplant Access Remains Unequal for Patients with Intellectual Disabilities

A Medicare analysis of nearly 13,000 patients with intellectual or developmental disabilities found they were 22% less likely to be evaluated for a kidney transplant and 38% less likely to receive one compared with matched controls. State anti-discrimination laws, even those with enforcement mechanisms, were not associated with improved access. The researchers suggest that legislation alone may not eliminate these disparities without additional efforts.
The study analyzed Medicare data from nearly 13,000 patients with intellectual or developmental disabilities, including conditions such as autism, cerebral palsy, and Down syndrome. Compared with matched controls, these patients were 22% less likely to undergo transplant evaluation and 38% less likely to receive a kidney. The researchers examined whether state anti-discrimination laws, particularly those with enforcement mechanisms like private right of action or expedited case review, improved access.
Forty states currently have laws prohibiting disability-based discrimination in organ transplantation. However, the analysis found no significant association between these legal provisions and improved evaluation or receipt rates. The authors suggested that legal protections may not translate into clinical practice changes, noting that discriminatory treatment can be difficult to identify and prove. They proposed complementary strategies including electronic health record-based registries for automatic referral and allowing patient or advocate participation in transplant committee decisions.
This study could influence how policymakers and healthcare institutions approach transplant equity for vulnerable populations. If legislation alone proves insufficient, transplant centers may face growing pressure to implement transparency measures and bias-reduction training. Patients with intellectual disabilities and their families could benefit from increased awareness of legal protections, while advocacy groups may push for systemic changes beyond statutory fixes. The findings could also inform broader discussions about implicit bias in organ allocation and the need for accountability mechanisms that translate legal rights into clinical reality.